{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T21:19:39Z","timestamp":1792876779295,"version":"4.5.0"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004794","name":"Centre National de la Recherche Scientifique","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cbi.2024.110973","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T06:23:00Z","timestamp":1712038980000},"page":"110973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["The risk associated with organophosphorus nerve agents: from their discovery to their unavoidable threat, current medical countermeasures and perspectives"],"prefix":"10.1016","volume":"395","author":[{"given":"Camille","family":"Voros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Timperley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Nachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Baati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.110973_bib1","series-title":"Organophosphorus Pestic.","first-page":"1","article-title":"A history","author":"Eto","year":"1974"},{"key":"10.1016\/j.cbi.2024.110973_bib2","series-title":"Best Synth. Methods Organophosphorus V Chem.","first-page":"12","article-title":"General overview","author":"Timperley","year":"2015"},{"key":"10.1016\/j.cbi.2024.110973_bib3","first-page":"325","article-title":"The history of cholinesterase inhibitors: who was Moschnin(e)?","volume":"63","author":"Petroianu","year":"2008","journal-title":"Pharm. Times"},{"key":"10.1016\/j.cbi.2024.110973_bib4","first-page":"427","article-title":"Synthesis of tetraethyl pyrophosphate (TEPP): from physician Abbot and pharmacist Riegel to chemist Nylen","volume":"70","author":"Petroianu","year":"2015","journal-title":"Pharm. Times"},{"key":"10.1016\/j.cbi.2024.110973_bib5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.31482\/mmsl.2015.023","article-title":"History of organophosphorus cholinesterase inhibitors & reactivators","volume":"84","author":"Petroianu","year":"2015","journal-title":"Mil. Med. Sci. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib6","series-title":"Cholinesterases Anticholinesterase Agents","first-page":"428","article-title":"Structure-activity relationships of the organophosphorus Anticholinesterase agents","author":"Holmstedt","year":"1963"},{"key":"10.1016\/j.cbi.2024.110973_bib7","series-title":"Best Synth. Methods Organophosphorus V Chem.","first-page":"155","article-title":"Phosphonyl compounds","author":"Timperley","year":"2015"},{"key":"10.1016\/j.cbi.2024.110973_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1021\/cr00044a004","article-title":"Michaelis-Arbuzov rearrangement","volume":"81","author":"Bhattacharya","year":"1981","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cbi.2024.110973_bib9","series-title":"Best Synth. Methods Organophosphorus V Chem.","first-page":"15","article-title":"General overview","author":"Timperley","year":"2015"},{"key":"10.1016\/j.cbi.2024.110973_bib10","series-title":"Fluor. Chem. Millenn.","first-page":"499","article-title":"Highly-toxic fluorine compounds","author":"Timperley","year":"2000"},{"key":"10.1016\/j.cbi.2024.110973_bib11","first-page":"780","article-title":"Pharmacists Adolf Schall and Ernst Ratzlaff and the synthesis of tabun-like compounds: a brief history","author":"Petroianu","year":"2014","journal-title":"Pharmazie"},{"key":"10.1016\/j.cbi.2024.110973_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.11622\/smedj.2014002","article-title":"Otto Loewi (1873\u20131961): Dreamer and Nobel laureate","volume":"55","author":"McCoy","year":"2014","journal-title":"Singapore Med. J."},{"key":"10.1016\/j.cbi.2024.110973_bib13","first-page":"67","article-title":"Otto Loewi, 1873-1961, Biogr. Mem. Fellows R","volume":"8","author":"Dale","year":"1962","journal-title":"Soc."},{"key":"10.1016\/j.cbi.2024.110973_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.crvi.2006.03.012","article-title":"Henry Dale and the discovery of acetylcholine","volume":"329","author":"Tansey","year":"2006","journal-title":"C. R. Biol."},{"key":"10.1016\/j.cbi.2024.110973_bib15","first-page":"77","article-title":"Henry Hallett Dale, 1875-1968, Biogr. Mem. Fellows R","volume":"16","author":"Feldberg","year":"1970","journal-title":"Soc."},{"key":"10.1016\/j.cbi.2024.110973_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/09647040600658229","article-title":"Neurosciences and research on chemical weapons of mass Destruction in Nazi Germany","volume":"15","author":"Schmaltz","year":"2006","journal-title":"J. Hist. Neurosci."},{"key":"10.1016\/j.cbi.2024.110973_bib17","series-title":"Hist. Dict. Nucl. Biol. Chem. Warf.","first-page":"196","article-title":"Soman","author":"Garrett","year":"2007"},{"key":"10.1016\/j.cbi.2024.110973_bib18","series-title":"Toxic: a History of Nerve Agents, from Nazi Germany to Putin's Russia","author":"Kaszeta","year":"2020"},{"key":"10.1016\/j.cbi.2024.110973_bib19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/jsfa.2740090808","article-title":"Amiton\u2014a new acaricide and scalicide","volume":"9","author":"Baldit","year":"1958","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.cbi.2024.110973_bib20","series-title":"Best Synth. Methods Organophosphorus V Chem.","first-page":"277","article-title":"Phosphonyl compounds","author":"Timperley","year":"2015"},{"key":"10.1016\/j.cbi.2024.110973_bib21","series-title":"Chem. Organophosphorus Compd.","first-page":"781","article-title":"The chemistry of organophosphorus chemical warfare agents","author":"Black","year":"1990"},{"key":"10.1016\/j.cbi.2024.110973_bib22","series-title":"Issues Toxicol","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1039\/9781782622413-00001","article-title":"Development, historical use and properties of chemical warfare agents","author":"Black","year":"2016"},{"key":"10.1016\/j.cbi.2024.110973_bib23","series-title":"Chemical weapons Disarmament in Russia: Problems and Prospects","author":"Smithson","year":"1995"},{"key":"10.1016\/j.cbi.2024.110973_bib25","series-title":"Hist. Dict. Nucl. Biol. Chem. Warf.","article-title":"Novichok","year":"2007"},{"key":"10.1016\/j.cbi.2024.110973_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e03153","article-title":"Hydrolysis and enzymatic degradation of Novichok nerve agents","volume":"6","author":"Harvey","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.cbi.2024.110973_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/24734306.2018.1475151","article-title":"Novichok agents: a historical, current, and toxicological perspective","volume":"2","author":"Chai","year":"2018","journal-title":"Toxicol. Commun."},{"key":"10.1016\/j.cbi.2024.110973_bib28","series-title":"Harvard Sussex Program Occasional Paper Issue 07","article-title":"Novichok nerve agents: Publicly available information about them and what it may mean for chemical arms control","author":"Robinson","year":"2019"},{"key":"10.1016\/j.cbi.2024.110973_bib29","series-title":"State Secrets: an Insider's Chronicle of the Russian Chemical Weapons Program","author":"Mirzayanov","year":"2008"},{"key":"10.1016\/j.cbi.2024.110973_bib30","series-title":"The [agent] Fate of Novichok","first-page":"26","author":"Mirzayanov","year":"2009"},{"key":"10.1016\/j.cbi.2024.110973_bib31","first-page":"40","article-title":"Interviewee with his head in a noose","author":"Vishnyakov","year":"1993","journal-title":"Novoye Vremya"},{"key":"10.1016\/j.cbi.2024.110973_bib33","unstructured":"Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on their Destruction, OPCW (n.d.). https:\/\/www.opcw.org\/chemical-weapons-convention (accessed March 11, 2024)."},{"key":"10.1016\/j.cbi.2024.110973_bib34","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1021\/acs.jchemed.0c00547","article-title":"Nomenclature, chemical Abstracts Service numbers, isomer Enumeration, ring Strain, and Stereochemistry: what Does any of this have to do with an international chemical Disarmament and Nonproliferation treaty?","volume":"97","author":"Pontes","year":"2020","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.cbi.2024.110973_bib35","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1021\/acs.jchemed.0c01023","article-title":"Comment on \u201cNomenclature, chemical Abstracts Service numbers, isomer Enumeration, ring Strain, and Stereochemistry: what Does any of this have to do with an international chemical Disarmament and Nonproliferation treaty?,\u201d","volume":"98","author":"R\u00fccker","year":"2021","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.cbi.2024.110973_bib36","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1021\/acs.jchemed.1c00134","article-title":"Reply to \u201ccomment on \u2018Nomenclature, chemical Abstracts Service numbers, isomer Enumeration, ring Strain, and Stereochemistry: what Does any of this have to do with an international chemical Disarmament and Nonproliferation treaty?,\u2019\u201d","volume":"98","author":"Timperley","year":"2021","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.cbi.2024.110973_bib37","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1515\/pac-2018-0803","article-title":"Advice from the scientific advisory board of the Organisation for the Prohibition of Chemical Weapons on isotopically labelled chemicals and stereoisomers in relation to the chemical weapons Convention","volume":"90","author":"Timperley","year":"2018","journal-title":"Pure Appl. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib38","series-title":"Consolidated text of adopted changes to Schedule 1 of the Annex on chemicals to the Chemical Weapons Convention, S\/1820\/2019","year":"2019"},{"key":"10.1016\/j.cbi.2024.110973_bib39","series-title":"Guidance for states Parties on Article VI declaration obligations and inspections following entry into force of changes to Schedule 1 of the Annex on Chemicals to the Chemical Weapons Convention, Addendum, S\/1821\/2019\/Rev.1\/Add.1","year":"2020"},{"key":"10.1016\/j.cbi.2024.110973_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2022.153322","article-title":"Newly scheduled carbamate compounds: a synopsis of their properties and development, and considerations for the scientific community","volume":"480","author":"Palermo","year":"2022","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2024.110973_bib41","article-title":"Adding novichok nerve agents to the CWC Annex on chemicals: a technical fix and its implications for the chemical weapons prohibition regime","author":"Kelle","year":"2022","journal-title":"UNIDIR"},{"key":"10.1016\/j.cbi.2024.110973_bib42","series-title":"Chemicals, Recommended Operating Procedures for Analysis in the Verification of Chemical Disarmament, Blue Book","first-page":"35","author":"Black","year":"2023"},{"key":"10.1016\/j.cbi.2024.110973_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0021-9673(94)80518-0","article-title":"Application of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry to the analysis of chemical warfare samples, found to contain residues of the nerve agent sarin, sulphur mustard and their degradation products","volume":"662","author":"Black","year":"1994","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.cbi.2024.110973_bib44","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/15569540701474328","article-title":"Environmental and biomedical sample analysis in support of allegations of use of chemical warfare agents","volume":"26","author":"Black","year":"2007","journal-title":"Toxin Rev."},{"key":"10.1016\/j.cbi.2024.110973_bib45","series-title":"Struct. Funct. Cholinesterases Relat. Proteins","article-title":"Blood cholinesterase activity levels of victims intoxicated with sarin in Matsumoto and Tokyo subway system","author":"Seto","year":"1998"},{"key":"10.1016\/j.cbi.2024.110973_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11419-017-0376-7","article-title":"Fatal sarin poisoning in Syria 2013: forensic verification within an international laboratory network","volume":"36","author":"John","year":"2018","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib49","series-title":"ACS Symp. Ser.","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/bk-2018-1288.ch001","article-title":"Chemical Disarmament in a Technologically evolving World","author":"Forman","year":"2018"},{"key":"10.1016\/j.cbi.2024.110973_bib51","first-page":"48","article-title":"The use of VX as a terrorist agent: action by Aum Shinrikyo of Japan and the death of Kim Jong-Nam in Malaysia: four case studies, Glob. Secur","volume":"5","author":"Tu","year":"2020","journal-title":"Health Sci. Policy"},{"key":"10.1016\/j.cbi.2024.110973_bib52","unstructured":"Malaysia - Statement by H.E. Ambassador Ahmad Nazri Yusof Permanent Representative of Malaysia to the OPCW at the Eighty-Seventh Session of the Executive Council, EC-87\/NAT.14, (2018). https:\/\/www.opcw.org\/sites\/default\/files\/documents\/EC\/87\/en\/ec87nat14_e_.pdf (accessed March 11, 2024)."},{"key":"10.1016\/j.cbi.2024.110973_bib53","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1007\/s00204-023-03571-8","article-title":"A-agents, misleadingly known as \u201cNovichoks\u201d: a narrative review","volume":"97","author":"Opravil","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bja.2019.04.061","article-title":"Organophosphorus nerve agent poisoning: managing the poisoned patient","volume":"123","author":"Hulse","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.cbi.2024.110973_bib59","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(20)32644-1","article-title":"Novichok nerve agent poisoning","volume":"397","author":"Steindl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2024.110973_bib61","series-title":"Toxic Phosphorus Esters: Chemistry, Metabolism, and Biological Effects","author":"O'Brien","year":"1960"},{"key":"10.1016\/j.cbi.2024.110973_bib62","series-title":"The Organic Chemistry of Phosphorus","author":"Kirby","year":"1967"},{"key":"10.1016\/j.cbi.2024.110973_bib63","series-title":"The Chemistry of Organophosphorus Pesticides, Softcover Reprint of the Original 2","author":"Fest","year":"1982"},{"key":"10.1016\/j.cbi.2024.110973_bib64","series-title":"Best Synth. Methods Organophosphorus V Chem.","first-page":"17","article-title":"General overview","author":"Timperley","year":"2015"},{"key":"10.1016\/j.cbi.2024.110973_bib65","first-page":"776","article-title":"Toxicity of phosphor esters: Willy Lange (1900-1976) and Gerda von Krueger (1907-after 1970)","author":"Petroianu","year":"2010","journal-title":"Pharm. - Int. J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2024.110973_bib66","first-page":"1598","article-title":"\u00dcber ester der Monofluorphosphors\u00e4ure, Berichte Dtsch","volume":"65","author":"Lange","year":"1932","journal-title":"Chem. Ges. B Ser."},{"key":"10.1016\/j.cbi.2024.110973_bib67","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/rtph.2001.1517","article-title":"Genetic polymorphisms in assessing Interindividual Variability in delivered dose","volume":"35","author":"Haber","year":"2002","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib68","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1021\/tx7002504","article-title":"Mechanism-based Inactivation of human cytochromes P450s: experimental characterization, reactive intermediates, and clinical implications","volume":"21","author":"Hollenberg","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-4274(99)00044-2","article-title":"The role of metabolism in determining susceptibility to parathion toxicity in man","volume":"107","author":"Mutch","year":"1999","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib70","series-title":"Impr\u00e9gnation de la population fran\u00e7aise par les organophosphor\u00e9s sp\u00e9cifiques et non sp\u00e9cifiques","author":"Tagne-Fotso","year":"2021"},{"key":"10.1016\/j.cbi.2024.110973_bib71","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jes.2022.04.023","article-title":"Organophosphate pesticides an emerging environmental contaminant: Pollution, toxicity, bioremediation progress, and remaining challenges","volume":"127","author":"Mali","year":"2023","journal-title":"J. Environ. Sci."},{"key":"10.1016\/j.cbi.2024.110973_bib72","series-title":"StatPearls","article-title":"Organophosphate toxicity","author":"Robb","year":"2023"},{"key":"10.1016\/j.cbi.2024.110973_bib73","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(15)70134-8","article-title":"Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate","volume":"16","author":"Guyton","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cbi.2024.110973_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002671","article-title":"Organophosphate exposures during pregnancy and child neurodevelopment: Recommendations for essential policy reforms","volume":"15","author":"Hertz-Picciotto","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.cbi.2024.110973_bib75","series-title":"About Pesticide Tolerances","year":"2015"},{"key":"10.1016\/j.cbi.2024.110973_bib76","author":"Staff"},{"key":"10.1016\/j.cbi.2024.110973_bib77","series-title":"2009\/128\/EC of the European Parliament and of the Council of 21 October 2009 establishing a framework for Community action to achieve the sustainable use of pesticides","year":"2009"},{"key":"10.1016\/j.cbi.2024.110973_bib78","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tox.2019.01.004","article-title":"Advice on assistance and protection provided by the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 1. On medical care and treatment of injuries from nerve agents","volume":"415","author":"Timperley","year":"2019","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2024.110973_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152967","article-title":"Advice on assistance and protection provided by the Scientific Advisory Board of the Organisation for the Prohibition of Chemical Weapons: Part 3. On medical care and treatment of injuries from sulfur mustard","volume":"463","author":"Timperley","year":"2021","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2024.110973_bib81","series-title":"Chemical Warfare Toxicology: Fundamental Aspects","year":"2016"},{"key":"10.1016\/j.cbi.2024.110973_bib82","series-title":"Chemical Warfare Toxicology: Management of Poisoning","year":"2016"},{"key":"10.1016\/j.cbi.2024.110973_bib83","series-title":"Best Synth. Methods Organophosphorus V Chem.","first-page":"33","article-title":"General overview","author":"Timperley","year":"2015"},{"key":"10.1016\/j.cbi.2024.110973_bib84","article-title":"Toxicity and medical countermeasure studies on the organophosphorus nerve agents VM and VX","volume":"471","author":"Rice","year":"2015","journal-title":"Proc. R. Soc. Math. Phys. Eng. Sci."},{"key":"10.1016\/j.cbi.2024.110973_bib91","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bcp.2018.01.044","article-title":"Cholinesterases and the fine line between poison and remedy","volume":"153","author":"Pope","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib92","doi-asserted-by":"crossref","first-page":"14642","DOI":"10.1021\/bi971425+","article-title":"Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase","volume":"36","author":"Saxena","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2024.110973_bib93","first-page":"266","article-title":"Counteracting poisoning with chemical warfare nerve agents","volume":"71","author":"Hrvat","year":"2020","journal-title":"Arch. Ind. Hyg. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib85","series-title":"Handb. Toxicol. Chem. Warf. Agents","article-title":"Organophosphate nerve agents","author":"Young","year":"2020"},{"key":"10.1016\/j.cbi.2024.110973_bib86","series-title":"Handb. Toxicol. Chem. Warf. Agents","article-title":"Toxicokinetic aspects of nerve agents and vesicants","author":"John","year":"2020"},{"key":"10.1016\/j.cbi.2024.110973_bib87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S1049023X0000649X","article-title":"Mustard gas or sulfur mustard: an old chemical agent as a new terrorist threat","volume":"24","author":"Wattana","year":"2009","journal-title":"Prehospital Disaster Med."},{"key":"10.1016\/j.cbi.2024.110973_bib88","series-title":"Rev. Acute Hum.-Toxic. Estim. Sel. Chem.-Warf. Agents","article-title":"Review of acute human-toxicity estimates for VX","year":"1997"},{"key":"10.1016\/j.cbi.2024.110973_bib89","doi-asserted-by":"crossref","first-page":"17640","DOI":"10.1016\/S0021-9258(19)37091-7","article-title":"Mutagenesis of human acetylcholinesterase. Identification of residues involved in catalytic activity and in polypeptide folding","volume":"267","author":"Shafferman","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib90","series-title":"Pestic. Toxicol.","first-page":"1457","article-title":"Cholinesterases","author":"Wilson","year":"2010"},{"key":"10.1016\/j.cbi.2024.110973_bib94","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0003-4509(05)82274-6","article-title":"Structure tridimensionnelle de la butyrylcholinest\u00e9rase humaine","volume":"63","author":"Nachon","year":"2005","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.cbi.2024.110973_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115910","article-title":"Drug and pro-drug substrates and pseudo-substrates of human butyrylcholinesterase","volume":"218","author":"Masson","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib96","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1002\/chem.201805075","article-title":"Resurrection and reactivation of acetylcholinesterase and butyrylcholinesterase","volume":"25","author":"Franjesevic","year":"2019","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.cbi.2024.110973_bib97","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/aps.2015.66","article-title":"Ion channels gated by acetylcholine and serotonin: structures, biology, and drug discovery","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2024.110973_bib98","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0047-6374(01)00309-8","article-title":"Acetylcholinesterase in Alzheimer's disease","volume":"122","author":"Talesa","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.cbi.2024.110973_bib99","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1678899","article-title":"Atomic structure of acetylcholinesterase from Torpedo californica : a prototypic acetylcholine-binding protein","volume":"253","author":"Sussman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.cbi.2024.110973_bib100","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1107\/S0907444900010659","article-title":"Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II","volume":"56","author":"Kryger","year":"2000","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.cbi.2024.110973_bib101","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib102","series-title":"Human Cholinesterases and Anticholinesterases","author":"Soreq","year":"2014"},{"key":"10.1016\/j.cbi.2024.110973_bib103","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2010.01.042","article-title":"Acetylcholinesterase: from 3D structure to function","volume":"187","author":"Dvir","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib104","doi-asserted-by":"crossref","first-page":"29256","DOI":"10.1074\/jbc.M603018200","article-title":"Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding","volume":"281","author":"Bourne","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib105","series-title":"Best Synth. Methods Organophosphorus V Chem.","first-page":"24","article-title":"General overview","author":"Timperley","year":"2015"},{"key":"10.1016\/j.cbi.2024.110973_bib106","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.taap.2005.02.025","article-title":"Detoxification of organophosphate nerve agents by bacterial phosphotriesterase","volume":"207","author":"Ghanem","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib107","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.pharmthera.2013.04.009","article-title":"The value of novel oximes for treatment of poisoning by organophosphorus compounds","volume":"139","author":"Worek","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2024.110973_bib108","series-title":"Pract. Med. Chem.","first-page":"723","article-title":"Preparation of water-soluble compounds by covalent attachment of solubilizing moieties","author":"Wermuth","year":"2015"},{"key":"10.1016\/j.cbi.2024.110973_bib109","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1039\/C2MD00258B","article-title":"1,1\u2032-(Propane-1,3-diyl)bis(4-tert-butylpyridinium) di(methanesulfonate) protects guinea pigs from soman poisoning when used as part of a combined therapy","volume":"3","author":"Timperley","year":"2012","journal-title":"Med Chem Commun"},{"key":"10.1016\/j.cbi.2024.110973_bib110","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1476-5381.1989.tb11972.x","article-title":"Prevention of physostigmine-, DFP-, and diazinon-induced acute toxicity by monoethylcholine and N-aminodeanol","volume":"97","author":"Patterson","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib111","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.toxlet.2019.12.010","article-title":"Assessment of false transmitters as treatments for nerve agent poisoning","volume":"321","author":"Whitmore","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib112","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s002040050340","article-title":"Pharmacological effects of oximes: how relevant are they?","volume":"70","author":"Van Helden","year":"1996","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib113","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00204-012-0977-1","article-title":"The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors","volume":"87","author":"Soukup","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib114","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/0006-3002(55)90040-8","article-title":"A powerful reactivator of alkylphosphate-inhibited acetylcholinesterase","volume":"18","author":"Wilson","year":"1955","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2024.110973_bib115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0006-2952(99)00117-3","article-title":"Characterization of O,O-diethylphosphoryl oximes as inhibitors of cholinesterases and substrates of phosphotriesterases","volume":"58","author":"Leader","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib116","series-title":"Handb. Toxicol. Chem. Warf. Agents","article-title":"Novel cholinesterase reactivators","author":"Musilek","year":"2020"},{"key":"10.1016\/j.cbi.2024.110973_bib117","article-title":"Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents","volume":"11","author":"Mercey","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.cbi.2024.110973_bib118","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1039\/B609658C","article-title":"Revisiting the reactivity of oximate \u03b1-nucleophiles with electrophilic phosphorus centers. Relevance to detoxification of sarin, soman and DFP under mild conditions","volume":"4","author":"Terrier","year":"2006","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib119","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1021\/jp9067087","article-title":"A Reliable and efficient first principles-based method for predicting pKa values. 2. Organic acids","volume":"114","author":"Zhang","year":"2010","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.cbi.2024.110973_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114377","article-title":"Halogen substituents enhance oxime nucleophilicity for reactivation of cholinesterases inhibited by nerve agents","volume":"238","author":"Zorbaz","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib121","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1021\/acsmedchemlett.9b00021","article-title":"Synthesis and molecular properties of nerve agent reactivator HL\u00f6-7 dimethanesulfonate","volume":"10","author":"Hsu","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib122","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1039\/C9RA08599H","article-title":"Recent developments on oximes to improve the blood brain barrier penetration for the treatment of organophosphorus poisoning: a review","volume":"10","author":"Faiz Norrrahim","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.cbi.2024.110973_bib123","series-title":"Chem. Warf. Toxicol.","article-title":"Treatment of nerve agent poisoning","author":"Thiermann","year":"2016"},{"key":"10.1016\/j.cbi.2024.110973_bib125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jemermed.2007.09.043","article-title":"Organophosphate antidote auto-injectors vs. traditional administration: a time motion study","volume":"37","author":"Rebmann","year":"2009","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.cbi.2024.110973_bib126","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s002040050244","article-title":"Treatment of organophosphate poisoning in pigs: antidote administration by a new binary autoinjector","volume":"70","author":"G\u00f6ransson-Nyberg","year":"1995","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib127","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.annfar.2009.02.039","article-title":"Int\u00e9r\u00eat de la seringue Ineurope\u00ae devant une intoxication par neurotoxique de guerre","volume":"28","author":"Rousseau","year":"2009","journal-title":"Ann. Fr. Anesth. R\u00e9animation"},{"key":"10.1016\/j.cbi.2024.110973_bib128","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00139709-200625040-00009","article-title":"The role of oximes in the treatment of nerve agent poisoning in civilian Casualties","volume":"25","author":"Marrs","year":"2006","journal-title":"Toxicol. Rev."},{"key":"10.1016\/j.cbi.2024.110973_bib130","doi-asserted-by":"crossref","first-page":"12199","DOI":"10.1021\/jp307790v","article-title":"Aging mechanism of soman inhibited acetylcholinesterase","volume":"116","author":"Sirin","year":"2012","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.cbi.2024.110973_bib131","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1042\/bj3180833","article-title":"Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre","volume":"318","author":"Shafferman","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.cbi.2024.110973_bib132","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1021\/acs.jmedchem.7b01620","article-title":"Demonstration of in vitro resurrection of aged acetylcholinesterase after exposure to organophosphorus chemical nerve agents","volume":"61","author":"Zhuang","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib133","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cbi.2010.02.003","article-title":"Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure","volume":"187","author":"Haigh","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib134","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bbr.2009.05.002","article-title":"Gulf War illness: effects of repeated stress and pyridostigmine treatment on blood\u2013brain barrier permeability and cholinesterase activity in rat brain","volume":"203","author":"Amourette","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.cbi.2024.110973_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108264","article-title":"Pyridostigmine bromide exposure creates chronic, underlying neuroimmune disruption in the gastrointestinal tract and brain that alters responses to palmitoylethanolamide in a mouse model of Gulf War Illness","volume":"179","author":"Hernandez","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2024.110973_bib136","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.psyneuen.2018.07.015","article-title":"Pathophysiology in a model of Gulf war illness: Contributions of pyridostigmine bromide and stress","volume":"96","author":"Macht","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.cbi.2024.110973_bib141","first-page":"112","article-title":"Overcoming blood\u2013brain barrier transport: Advances in nanoparticle-based drug delivery strategies, Mater","volume":"37","author":"Ding","year":"2020","journal-title":"Today Off."},{"key":"10.1016\/j.cbi.2024.110973_bib137","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1021\/jm050518j","article-title":"Analogues with fluorescent leaving groups for screening and selection of enzymes that efficiently hydrolyze organophosphorus nerve agents","volume":"49","author":"Brise\u00f1o-Roa","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib138","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/protein\/gzq076","article-title":"Phosphotriesterase variants with high methylphosphonatase activity and strong negative trade-off against phosphotriesters","volume":"24","author":"Brise\u00f1o-Roa","year":"2011","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.cbi.2024.110973_bib139","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.cbi.2013.06.012","article-title":"Progress in the development of enzyme-based nerve agent bioscavengers","volume":"206","author":"Nachon","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib140","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cbi.2024.110973_bib142","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: Physiology and strategies for drug delivery","volume":"165\u2013166","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2024.110973_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115443","article-title":"The tertiary oxime monoisonitrosoacetone penetrates the brain, reactivates inhibited acetylcholinesterase, and reduces mortality and morbidity following lethal sarin intoxication in guinea pigs","volume":"415","author":"Shih","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib144","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1021\/acs.jmedchem.1c01748","article-title":"A new class of bi- and trifunctional sugar oximes as antidotes against organophosphorus poisoning","volume":"65","author":"Da Silva","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/10717544.2022.2152132","article-title":"HI-6-loaded PEGylated liposomes: an on-site first-aid strategy for acute organophosphorus agent poisoning","volume":"30","author":"Shen","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.cbi.2024.110973_bib146","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.3390\/pharmaceutics14091950","article-title":"Oxime therapy for brain AChE reactivation and neuroprotection after organophosphate poisoning","volume":"14","author":"Kuznetsova","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2024.110973_bib147","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.colsurfb.2018.07.049","article-title":"Mixed cationic liposomes for brain delivery of drugs by the intranasal route: the acetylcholinesterase reactivator 2-PAM as encapsulated drug model","volume":"171","author":"Pashirova","year":"2018","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.cbi.2024.110973_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106406","article-title":"Preparation of an HI-6-loaded brain-targeted liposomes based on the nasal delivery route and the evaluation of its reactivation of central toxic acetylcholinesterase","volume":"184","author":"Fan","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.cbi.2024.110973_bib149","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.cbi.2024.110973_bib150","doi-asserted-by":"crossref","first-page":"13152","DOI":"10.1021\/acs.jmedchem.1c00910","article-title":"Strategies for structural modification of small molecules to improve blood\u2013brain barrier penetration: a recent perspective","volume":"64","author":"Xiong","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib151","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00204-020-02797-0","article-title":"Organophosphorus compounds and oximes: a critical review","volume":"94","author":"Worek","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib152","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bcp.2004.07.038","article-title":"Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes","volume":"68","author":"Worek","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib153","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.toxlet.2015.07.007","article-title":"Investigation of the reactivation kinetics of a large series of bispyridinium oximes with organophosphate-inhibited human acetylcholinesterase","volume":"244","author":"Winter","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib154","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0003-9861(58)90077-8","article-title":"Molecular complementariness as basis for reactivation of alkyl phosphate-inhibited enzyme","volume":"77","author":"Wilson","year":"1958","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2024.110973_bib155","series-title":"Handb. Toxicol. Chem. Warf. Agents","first-page":"1145","article-title":"Pyridinium oximes in the treatment of poisoning with organophosphorus compounds","author":"Jokanovi\u0107","year":"2020"},{"key":"10.1016\/j.cbi.2024.110973_bib156","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0272-0590(81)80058-9","article-title":"Toxicology and pharmacology of bispyridinium oximes insight into the mechanism of action vs Soman poisoning in vivo","volume":"1","author":"Clement","year":"1981","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib157","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/096032719101000204","article-title":"HI-6 in man: efficacy of the oxime in poisoning by organophosphorus insecticides","volume":"10","author":"Kusic","year":"1991","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib158","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/toxsci\/5.6part2.89","article-title":"HI-6 in man: blood levels, urinary excretion, and tolerance after intramuscular administration of the oxime to healthy volunteers","volume":"5","author":"Ku\u0161i\u0107","year":"1985","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2024.110973_bib159","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00334636","article-title":"Studies on the stability and decomposition of the Hagedorn-oxime HL\u00f6 7 in aqueous solution","volume":"63","author":"Eyer","year":"1989","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib160","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/15376510903213892","article-title":"Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose","volume":"19","author":"Shih","year":"2009","journal-title":"Toxicol. Mech. Methods"},{"key":"10.1016\/j.cbi.2024.110973_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113084","article-title":"Theoretical assessment of the performances of commercial oximes on the reactivation of acetylcholinesterase inhibited by the nerve agent A-242 (novichok)","volume":"165","author":"Santos","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110622","article-title":"Molecular modeling of Mannich phenols as reactivators of human acetylcholinesterase inhibited by A-series nerve agents","volume":"382","author":"Vieira","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib163","doi-asserted-by":"crossref","first-page":"5673","DOI":"10.1016\/j.bmcl.2006.08.011","article-title":"Synthesis of asymmetrical bispyridinium compounds bearing cyano-moiety and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase","volume":"16","author":"Musilek","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib164","doi-asserted-by":"crossref","first-page":"6733","DOI":"10.1016\/j.bmc.2007.08.002","article-title":"Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker\u2014preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase","volume":"15","author":"Musilek","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib165","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.bmc.2010.12.021","article-title":"Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage\u2014preparation, in vitro screening and molecular docking","volume":"19","author":"Musilek","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib166","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.tox.2006.08.003","article-title":"Evaluation of monoquaternary pyridinium oximes potency to reactivate tabun-inhibited human acetylcholinesterase","volume":"233","author":"Od\u017eak","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2024.110973_bib167","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1016\/S0040-4039(03)00538-0","article-title":"Synthesis of a potential reactivator of acetylcholinesterase\u20141-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)propane dibromide","volume":"44","author":"Ku\u010da","year":"2003","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib168","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1016\/S0960-894X(03)00751-0","article-title":"Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase","volume":"13","author":"Ku\u010da","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib169","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.bmcl.2006.01.065","article-title":"Quaternary salts of 4,3\u2032 and 4,4\u2032 bis-pyridinium monooximes. Part 2: synthesis and biological activity","volume":"16","author":"Srinivas Rao","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib170","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.taap.2007.09.021","article-title":"Blood\u2013brain barrier penetration of novel pyridinealdoxime methiodide (PAM)-type oximes examined by brain microdialysis with LC-MS\/MS","volume":"227","author":"Okuno","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib171","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00044-012-0128-5","article-title":"In vitro reactivation of organophosphorus (OP)-inhibited electric eel acetylcholinesterase by novel monoquaternary pyridinium oximes","volume":"22","author":"Acharya","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.cbi.2024.110973_bib172","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1021\/acs.jmedchem.8b01398","article-title":"Pyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents","volume":"61","author":"Zorbaz","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib173","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jat.1084","article-title":"Effective bisquaternary reactivators of tabun-inhibited AChE","volume":"25","author":"Kuca","year":"2005","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib174","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ejmech.2008.02.029","article-title":"Synthesis and evaluation of novel bis-pyridinium oximes as reactivators of DFP-inhibited acetylcholinesterase","volume":"44","author":"Acharya","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib175","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1742-7843.2009.00421.x","article-title":"Reactivation of human brain homogenate cholinesterases inhibited by tabun using newly developed oximes K117 and K127","volume":"105","author":"Kuca","year":"2009","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib176","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.tiv.2007.10.006","article-title":"In vitro reactivation of sarin inhibited electric eel acetylcholinesterase by bis-pyridinium oximes bearing methoxy ether linkages","volume":"22","author":"Acharya","year":"2008","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2024.110973_bib177","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1476-5381.1955.tb00106.x","article-title":"The reactivation by oximes and hydroxamic acids of cholinesterase inhibited by organo-phosphorus compounds","volume":"10","author":"Childs","year":"1955","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/j.cbi.2024.110973_bib178","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1021\/jm00197a006","article-title":"Antidotes to organophosphate poisoning. 2. Thiadiazole-5-carboxaldoximes","volume":"22","author":"Benschop","year":"1979","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib179","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1021\/jm00161a008","article-title":"Nonquaternary cholinesterase reactivators. 3. 3(5)-Substituted 1,2,4-oxadiazol-5(3)-aldoximes and 1,2,4-oxadiazole-5(3)-thiocarbohydroximates as reactivators of organophosphonate-inhibited eel and human acetylcholinesterase in vitro","volume":"29","author":"Bedford","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib180","doi-asserted-by":"crossref","first-page":"19422","DOI":"10.1074\/jbc.M111.230656","article-title":"New structural scaffolds for centrally acting oxime reactivators of phosphylated cholinesterases","volume":"286","author":"Sit","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib181","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejmech.2014.03.044","article-title":"Design, synthesis and biological evaluation of novel tetrahydroacridine pyridine- aldoxime and -amidoxime hybrids as efficient uncharged reactivators of nerve agent-inhibited human acetylcholinesterase","volume":"78","author":"Kliachyna","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib182","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1074\/jbc.M111.333732","article-title":"Refinement of structural leads for centrally acting oxime reactivators of phosphylated cholinesterases","volume":"287","author":"Radi\u0107","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib183","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cbi.2017.09.016","article-title":"The biodistribution and pharmacokinetics of the oxime acetylcholinesterase reactivator RS194B in guinea pigs","volume":"277","author":"Malfatti","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib184","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cbi.2017.07.003","article-title":"Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor","volume":"274","author":"Rosenberg","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.toxlet.2017.10.025","article-title":"Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques","volume":"293","author":"Rosenberg","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib186","article-title":"A single post\u2010exposure oxime RS194B treatment rapidly reactivates acetylcholinesterase and reverses acute symptoms in macaques exposed to diethylphosphorothioate parathion and chlorpyrifos insecticides","author":"Rosenberg","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2024.110973_bib187","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/cbic.201500348","article-title":"Discovery of new classes of compounds that reactivate acetylcholinesterase inhibited by organophosphates","volume":"16","author":"Katz","year":"2015","journal-title":"Chembiochem"},{"key":"10.1016\/j.cbi.2024.110973_bib188","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cbi.2016.04.002","article-title":"Probing the activity of a non-oxime reactivator for acetylcholinesterase inhibited by organophosphorus nerve agents","volume":"259","author":"Cadieux","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib189","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejmech.2018.08.016","article-title":"Discovery of a potent non-oxime reactivator of nerve agent inhibited human acetylcholinesterase","volume":"157","author":"de Koning","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110078","article-title":"N-substituted arylhydroxamic acids as acetylcholinesterase reactivators","volume":"365","author":"Bondar","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib191","doi-asserted-by":"crossref","DOI":"10.1002\/chem.202200678","article-title":"Broad\u2010spectrum antidote discovery by untangling the reactivation mechanism of nerve\u2010agent\u2010inhibited acetylcholinesterase","volume":"28","author":"Lindgren","year":"2022","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.cbi.2024.110973_bib192","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tox.2006.11.061","article-title":"Acetylcholinesterase: Converting a vulnerable target to a template for antidotes and detection of inhibitor exposure","volume":"233","author":"Taylor","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2024.110973_bib193","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.bmc.2010.10.059","article-title":"Peripheral site ligand\u2013oxime conjugates: a novel concept towards reactivation of nerve agent-inhibited human acetylcholinesterase","volume":"19","author":"De Koning","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib194","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1039\/c1cc10787a","article-title":"First efficient uncharged reactivators for the dephosphylation of poisoned human acetylcholinesterase","volume":"47","author":"Mercey","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.cbi.2024.110973_bib195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.toxlet.2011.04.004","article-title":"Peripheral site ligand conjugation to a non-quaternary oxime enhances reactivation of nerve agent-inhibited human acetylcholinesterase","volume":"206","author":"De Koning","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib196","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cbi.2016.05.035","article-title":"Design and synthesis of N-substituted-2-hydroxyiminoacetamides and interactions with cholinesterases","volume":"259","author":"Marakovi\u0107","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib197","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1016\/j.bmcl.2014.10.055","article-title":"New efficient imidazolium aldoxime reactivators for nerve agent-inhibited acetylcholinesterase","volume":"24","author":"Wei","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib198","doi-asserted-by":"crossref","first-page":"4497","DOI":"10.1016\/j.bmc.2017.06.041","article-title":"Conjugates of salicylaldoximes and peripheral site ligands: novel efficient nonquaternary reactivators for nerve agent-inhibited acetylcholinesterase","volume":"25","author":"Wei","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib199","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.toxlet.2019.12.016","article-title":"Evaluation of high-affinity phenyltetrahydroisoquinoline aldoximes, linked through anti-triazoles, as reactivators of phosphylated cholinesterases","volume":"321","author":"Ma\u010dek Hrvat","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2016.01.015","article-title":"Novel nonquaternary reactivators showing reactivation efficiency for soman-inhibited human acetylcholinesterase","volume":"246","author":"Wei","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib201","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.1021\/acs.jmedchem.7b01083","article-title":"Application of the Ugi multicomponent reaction in the synthesis of reactivators of nerve agent inhibited acetylcholinesterase","volume":"60","author":"De Koning","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib202","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s00204-021-02981-w","article-title":"Development of versatile and potent monoquaternary reactivators of acetylcholinesterase","volume":"95","author":"Gorecki","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cbi.2012.09.023","article-title":"Syntheses and in vitro evaluations of uncharged reactivators for human acetylcholinesterase inhibited by organophosphorus nerve agents","volume":"203","author":"Renou","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib204","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1039\/C4CC00561A","article-title":"Tryptoline-3-hydroxypyridinaldoxime conjugates as efficient reactivators of phosphylated human acetyl and butyrylcholinesterases","volume":"50","author":"Renou","year":"2014","journal-title":"Chem Commun"},{"key":"10.1016\/j.cbi.2024.110973_bib205","doi-asserted-by":"crossref","first-page":"7630","DOI":"10.1021\/acs.jmedchem.8b00592","article-title":"Structure-based optimization of nonquaternary reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents","volume":"61","author":"Santoni","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib206","doi-asserted-by":"crossref","first-page":"9675","DOI":"10.1002\/chem.201801394","article-title":"Potent 3-hydroxy-2-pyridine aldoxime reactivators of organophosphate-inhibited cholinesterases with predicted blood-brain barrier penetration","volume":"24","author":"Zorbaz","year":"2018","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.cbi.2024.110973_bib207","doi-asserted-by":"crossref","first-page":"17929","DOI":"10.1039\/C5RA25477A","article-title":"Synthesis and in vitro evaluation of donepezil-based reactivators and analogues for nerve agent-inhibited human acetylcholinesterase","volume":"6","author":"Renou","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.cbi.2024.110973_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2024.110973_bib209","series-title":"Broad Spectrum Reactivators of OPNA-Inhibition of Human Cholinesterases","author":"Baati","year":"2022"},{"key":"10.1016\/j.cbi.2024.110973_bib228","doi-asserted-by":"crossref","first-page":"110929","DOI":"10.1016\/j.cbi.2024.110929","article-title":"No-observed-adverse-effect-level (NOAEL) assessment as an optimized dose of cholinesterase reactivators for the treatment of exposure to warfare nerve agents in mice","volume":"392","author":"Trancart","year":"2024","journal-title":"Chemico-Biological Interactions"},{"key":"10.1016\/j.cbi.2024.110973_bib210","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1002\/chem.202002012","article-title":"Chemoselective hydrogenation of 6\u2010alkynyl\u20103\u2010fluoro\u20102\u2010pyridinaldoximes: access to first\u2010in\u2010class 6\u2010alkyl\u20103\u2010fluoro\u20102\u2010pyridinaldoxime scaffolds as new reactivators of sarin\u2010inhibited human acetylcholinesterase with increased blood\u2013brain barrier permeability","volume":"26","author":"Yerri","year":"2020","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.cbi.2024.110973_bib211","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.bmcl.2008.12.070","article-title":"Reactivation potency of fluorinated pyridinium oximes for acetylcholinesterases inhibited by paraoxon organophosphorus agent","volume":"19","author":"Jeong","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2024.110973_bib212","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1016\/j.bmc.2009.07.043","article-title":"Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent","volume":"17","author":"Jeong","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib213","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jfluchem.2005.05.004","article-title":"Fluorinated pyridine derivatives: Part 1. The synthesis of some mono- and bis-quaternary pyridine salts of potential use in the treatment of nerve agent poisoning","volume":"126","author":"Timperley","year":"2005","journal-title":"J. Fluor. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib214","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jfluchem.2011.05.028","article-title":"Synthesis of some fluorine-containing pyridinealdoximes of potential use for the treatment of organophosphorus nerve-agent poisoning","volume":"132","author":"Timperley","year":"2011","journal-title":"J. Fluor. Chem."},{"key":"10.1016\/j.cbi.2024.110973_bib215","series-title":"The Royal Society of Chemistry Historical Group Newsletter and Summary of Papers","article-title":"Member's publications","author":"Banks","year":"2012"},{"key":"10.1016\/j.cbi.2024.110973_bib216","series-title":"Fluor. Chem. Millenn.","first-page":"519","article-title":"Highly-toxic fluorine compounds","author":"Timperley","year":"2000"},{"key":"10.1016\/j.cbi.2024.110973_bib217","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0041-008X(80)90216-1","article-title":"Reactivating and protective effects of Pro-2-PAM in mice poisoned with paraoxon","volume":"55","author":"Bo\u0161kovi\u0107","year":"1980","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib218","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cbi.2010.02.015","article-title":"Pro-2-PAM therapy for central and peripheral cholinesterases","volume":"187","author":"DeMar","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib219","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.lfs.2011.09.019","article-title":"Oxidative mechanisms for the biotransformation of 1-methyl-1,6-dihydropyridine-2-carbaldoxime to pralidoxime chloride","volume":"89","author":"Khan","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2024.110973_bib220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cbi.2010.02.033","article-title":"Novel oximes as blood\u2013brain barrier penetrating cholinesterase reactivators","volume":"187","author":"Garcia","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2024.110973_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.etap.2020.103454","article-title":"Glycosylated-imidazole aldoximes as reactivators of pesticides inhibited AChE: synthesis and in-vitro reactivation study","volume":"80","author":"Sharma","year":"2020","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110973_bib222","doi-asserted-by":"crossref","first-page":"26501","DOI":"10.1021\/acsami.2c06025","article-title":"Zirconium metal\u2013organic polyhedra with dual behavior for organophosphate poisoning treatment","volume":"14","author":"Delgado","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.cbi.2024.110973_bib223","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-023-03587-0","article-title":"Strategies for enhanced bioavailability of oxime reactivators in the central nervous system","author":"Prchalova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2024.110973_bib224","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1021\/acsami.7b04163","article-title":"Nanoparticle-delivered 2-PAM for rat brain protection against paraoxon central toxicity","volume":"9","author":"Pashirova","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.cbi.2024.110973_bib225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2018.10.010","article-title":"Combination delivery of two oxime-loaded lipid nanoparticles: time-dependent additive action for prolonged rat brain protection","volume":"290","author":"Pashirova","year":"2018","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.cbi.2024.110973_bib226","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3390\/pharmaceutics15030772","article-title":"Recent progress of lipid nanoparticles-based lipophilic drug delivery: focus on surface modifications","volume":"15","author":"Seo","year":"2023","journal-title":"Pharmaceutics"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724001194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724001194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T12:50:11Z","timestamp":1716555011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724001194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":214,"alternative-id":["S0009279724001194"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110973","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk associated with organophosphorus nerve agents: from their discovery to their unavoidable threat, current medical countermeasures and perspectives","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110973"}}